“According to Roots Analysis, the AI in Clinical Trials Market is estimated to be worth USD $8.50 billion in 2035. The market is forecasted to grow at a compound annual growth rate (CAGR) of 16% in the forecast period.
The report encompasses the global industry’s size, current trends, regional market share, demand, recent advancements, and potential business prospects. The report’s title is “AI in Clinical Trials Market Size | Statistics Report, 2023 - 2035.”
AI in Clinical Trials Market Segmentation:
The AI in Clinical Trials Market (2nd Edition): AI Software and Service Providers, Distribution by Trial Phase (Phase I, Phase II and Phase III), Target Therapeutic Area (Cardiovascular Disorders, CNS Disorders, Infectious Diseases, Metabolic Disorders, Oncological Disorders and Other Disorders), End-user (Pharmaceutical and Biotechnology Companies, and Other End-users)
Regional Analysis of the AI in Clinical Trials Market
In terms of geographical segmentation, the AI in Clinical Trials Market is divided into North America, Europe, Asia Pacific, Latin America, Middle East and North Africa. The report features an extensive study of the current market landscape, market size and future opportunities associated with the AI in clinical trials market, during the given forecast period.
The following are the major objectives of the study:
• To delineate, depict, and predict the AI in Clinical Trials Market’s attributes based on Distribution by Trial Phase, Target Therapeutic Area, End-user and Key Geographical Regions.
• To furnish comprehensive information regarding the key factors influencing Industry growth, encompassing drivers, limitations, opportunities, and challenges.
• To conduct a strategic examination of micro-industries, focusing on their individual growth patterns, prospects, and contributions to the broader industry.
• To scrutinize Industry opportunities for key stakeholders and provide an in-depth analysis of the competitive landscape among major industry leaders.
• To project the dimensions of Industry segments across four major regions: North America, Europe, Asia Pacific, Latin America, Middle East and North Africa.
• To outline the profiles of key players in the industry and thoroughly assess their market shares and core competencies.
The major prominent/emerging key companies in the AI in Clinical Trials Market are.
Acclinate, AiCure, Aidar Health, Aitia, A.I. VALI, Ancora.ai, Antidote Technologies, Beacon Biosignals, BUDDI.AI, ConcertAI, Curify, Deep 6 AI, ICON, Innoplexus, Massive Bio, Median Technologies, Novadiscovery, Owkin, PHASTAR, SiteRx and Viz.ai.
Major Points in TOC:
- Preface
- Research Methodology
- Executive Summary
- Introduction
- Company Profiles
- Clinical Trial Analysis
- Partnerships And Collaborations
- Big Pharma Initiatives
- Value Creation Framework: A Strategic Guide To Address Unmet Needs In Clinical Trials
- Cost Saving Analysis TOC Continued…………….
Frequently Asked Questions
Which are the leading artificial intelligence companies in clinical trials market?
Which region captures the largest share in the AI in clinical trials market?
What are the upcoming trends in AI in clinical trial market?
What is the role of AI in electronic health records of clinical trials data?
How is AI and ML used in clinical trials?
To view more details on this report, click on the link:
https://www.rootsanalysis.com/reports/ai-based-clinical-trial-solutions.html
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com
Top comments (0)